Chinatsu Sakata-Sakurai

Company: Astellas Pharma

Job title: Vice President - Targeted Protein Degradation & Primary Focus Lead

Seminars:

Roundtable Discussion: Discussing Critical Challenges Faced in Clinical Trials for Degraders 9:30 am

How can we best use preclinical data to predict the right dose and dosing regimen? How can we best confirm PK/PD/Efficacy a clinical in clinical study?Read more

day: Day Two Until 10am

Targeting ‘Undruggable’ Targets: Pioneering Novel Applications of Heterobifunctional Degrade 9:45 am

Astellas’ long-term innovation strategy in Targeted Protein Degradation Learnings from the discovery and development of ASP3082 Accelerating progress through an integrated R&D approach and strategic collaborationsRead more

day: Day 1 - Until 10:15